0001993155-23-000001.txt : 20230912 0001993155-23-000001.hdr.sgml : 20230912 20230912124523 ACCESSION NUMBER: 0001993155-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230912 DATE AS OF CHANGE: 20230912 EFFECTIVENESS DATE: 20230912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Conjupro Biotherapeutics Inc. CENTRAL INDEX KEY: 0001993155 IRS NUMBER: 460913476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-491870 FILM NUMBER: 231249479 BUSINESS ADDRESS: STREET 1: 302 CARNEGIE CENTER BLVD, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-356-0210 MAIL ADDRESS: STREET 1: 302 CARNEGIE CENTER BLVD, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 D 1 primary_doc.xml X0708 D LIVE 0001993155 Conjupro Biotherapeutics Inc. 302 CARNEGIE CENTER BLVD, SUITE 100 PRINCETON NJ NEW JERSEY 08540 609-356-0210 DELAWARE None None Corporation true Qingxi Wang 302 Carnegie Center Blvd, Suite 100 Princeton NJ NEW JERSEY 08540 Executive Officer Director Haixing Wang 302 Carnegie Center Blvd, Suite 100 Princeton NJ NEW JERSEY 08540 Executive Officer Other Decline to Disclose 06b false 2023-09-01 false true false 0 67454852 9321686 58133166 false 1 0 0 0 false Conjupro Biotherapeutics Inc. /s/ Qingxi Wang Qingxi Wang CEO 2023-09-12